Lumasag, Cantongan T.
HRN: 10-52-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/17/2025
04/24/2025
ORAL
1-2 Drops
TID
Oral Sores
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes